Cargando…
Serum lipopolysaccharide neutralizing capacity in ischemic stroke
INTRODUCTION: Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034831/ https://www.ncbi.nlm.nih.gov/pubmed/32084157 http://dx.doi.org/10.1371/journal.pone.0228806 |
_version_ | 1783499951323480064 |
---|---|
author | Leskelä, Jaakko Pietiäinen, Milla Safer, Anton Lehto, Markku Metso, Jari Malle, Ernst Buggle, Florian Becher, Heiko Sundvall, Jouko Grau, Armin J. Pussinen, Pirkko J. Palm, Frederick |
author_facet | Leskelä, Jaakko Pietiäinen, Milla Safer, Anton Lehto, Markku Metso, Jari Malle, Ernst Buggle, Florian Becher, Heiko Sundvall, Jouko Grau, Armin J. Pussinen, Pirkko J. Palm, Frederick |
author_sort | Leskelä, Jaakko |
collection | PubMed |
description | INTRODUCTION: Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum LPS-neutralizing capacity (LPS-NC) in ischemic stroke. The association of LPS-NC and Aggregatibacter actinomycetemcomitans, a major microbial biomarker in periodontitis, was also investigated. MATERIALS AND METHODS: The assay to measure LPS-NC was set up by spiking serum samples with E. coli LPS. The LPS-NC, LPS-binding protein (LBP), soluble CD14 (sCD14), lipoprotein profiles, apo(lipoprotein) A-I, apoB, and phospholipid transfer protein (PLTP) activity, were determined in 98 ischemic stroke patients and 100 age- and sex-matched controls. Serum and saliva immune response to A. actinomycetemcomitans, its concentration in saliva, and serotype-distribution were examined. RESULTS: LPS-NC values ranged between 51–83% in the whole population. Although several of the LPS-NC determinants differed significantly between cases and controls (PLTP, sCD14, apoA-I, HDL-cholesterol), the levels did not (p = 0.056). The main determinants of LPS-NC were i) triglycerides (β = -0.68, p<0.001), and ii) HDL cholesterol (0.260, <0.001), LDL cholesterol (-0.265, <0.001), PLTP (-0.196, 0.011), and IgG against A. actinomycetemcomitans (0.174, 0.011). Saliva A. actinomycetemcomitans concentration was higher [log mean (95% CI), 4.39 (2.35–8.19) vs. 10.7 (5.45–21) genomes/ml, p = 0.023) and serotype D more frequent (4 vs. 0%, p = 0.043) in cases than controls. Serotypeablity or serotypes did not, however, relate to the LPS-NC. CONCLUSION: Serum LPS-NC comprised low PLTP-activity, triglyceride and LDL cholesterol concentrations, as well as high HDL cholesterol and IgG against A. actinomycetemcomitans. The present findings let us to conclude that LPS-NC did not associate with stroke. |
format | Online Article Text |
id | pubmed-7034831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-70348312020-02-27 Serum lipopolysaccharide neutralizing capacity in ischemic stroke Leskelä, Jaakko Pietiäinen, Milla Safer, Anton Lehto, Markku Metso, Jari Malle, Ernst Buggle, Florian Becher, Heiko Sundvall, Jouko Grau, Armin J. Pussinen, Pirkko J. Palm, Frederick PLoS One Research Article INTRODUCTION: Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum LPS-neutralizing capacity (LPS-NC) in ischemic stroke. The association of LPS-NC and Aggregatibacter actinomycetemcomitans, a major microbial biomarker in periodontitis, was also investigated. MATERIALS AND METHODS: The assay to measure LPS-NC was set up by spiking serum samples with E. coli LPS. The LPS-NC, LPS-binding protein (LBP), soluble CD14 (sCD14), lipoprotein profiles, apo(lipoprotein) A-I, apoB, and phospholipid transfer protein (PLTP) activity, were determined in 98 ischemic stroke patients and 100 age- and sex-matched controls. Serum and saliva immune response to A. actinomycetemcomitans, its concentration in saliva, and serotype-distribution were examined. RESULTS: LPS-NC values ranged between 51–83% in the whole population. Although several of the LPS-NC determinants differed significantly between cases and controls (PLTP, sCD14, apoA-I, HDL-cholesterol), the levels did not (p = 0.056). The main determinants of LPS-NC were i) triglycerides (β = -0.68, p<0.001), and ii) HDL cholesterol (0.260, <0.001), LDL cholesterol (-0.265, <0.001), PLTP (-0.196, 0.011), and IgG against A. actinomycetemcomitans (0.174, 0.011). Saliva A. actinomycetemcomitans concentration was higher [log mean (95% CI), 4.39 (2.35–8.19) vs. 10.7 (5.45–21) genomes/ml, p = 0.023) and serotype D more frequent (4 vs. 0%, p = 0.043) in cases than controls. Serotypeablity or serotypes did not, however, relate to the LPS-NC. CONCLUSION: Serum LPS-NC comprised low PLTP-activity, triglyceride and LDL cholesterol concentrations, as well as high HDL cholesterol and IgG against A. actinomycetemcomitans. The present findings let us to conclude that LPS-NC did not associate with stroke. Public Library of Science 2020-02-21 /pmc/articles/PMC7034831/ /pubmed/32084157 http://dx.doi.org/10.1371/journal.pone.0228806 Text en © 2020 Leskelä et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Leskelä, Jaakko Pietiäinen, Milla Safer, Anton Lehto, Markku Metso, Jari Malle, Ernst Buggle, Florian Becher, Heiko Sundvall, Jouko Grau, Armin J. Pussinen, Pirkko J. Palm, Frederick Serum lipopolysaccharide neutralizing capacity in ischemic stroke |
title | Serum lipopolysaccharide neutralizing capacity in ischemic stroke |
title_full | Serum lipopolysaccharide neutralizing capacity in ischemic stroke |
title_fullStr | Serum lipopolysaccharide neutralizing capacity in ischemic stroke |
title_full_unstemmed | Serum lipopolysaccharide neutralizing capacity in ischemic stroke |
title_short | Serum lipopolysaccharide neutralizing capacity in ischemic stroke |
title_sort | serum lipopolysaccharide neutralizing capacity in ischemic stroke |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034831/ https://www.ncbi.nlm.nih.gov/pubmed/32084157 http://dx.doi.org/10.1371/journal.pone.0228806 |
work_keys_str_mv | AT leskelajaakko serumlipopolysaccharideneutralizingcapacityinischemicstroke AT pietiainenmilla serumlipopolysaccharideneutralizingcapacityinischemicstroke AT saferanton serumlipopolysaccharideneutralizingcapacityinischemicstroke AT lehtomarkku serumlipopolysaccharideneutralizingcapacityinischemicstroke AT metsojari serumlipopolysaccharideneutralizingcapacityinischemicstroke AT malleernst serumlipopolysaccharideneutralizingcapacityinischemicstroke AT buggleflorian serumlipopolysaccharideneutralizingcapacityinischemicstroke AT becherheiko serumlipopolysaccharideneutralizingcapacityinischemicstroke AT sundvalljouko serumlipopolysaccharideneutralizingcapacityinischemicstroke AT grauarminj serumlipopolysaccharideneutralizingcapacityinischemicstroke AT pussinenpirkkoj serumlipopolysaccharideneutralizingcapacityinischemicstroke AT palmfrederick serumlipopolysaccharideneutralizingcapacityinischemicstroke |